Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-042718
Filing Date
2024-10-28
Accepted
2024-10-28 17:15:29
Documents
4
Period of Report
2024-10-28

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 417394
2 formdef14a_001.jpg GRAPHIC 8718
3 proxy_001.jpg GRAPHIC 2468445
4 proxy_002.jpg GRAPHIC 2915629
  Complete submission text file 0001493152-24-042718.txt   7845493
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41245 | Film No.: 241401850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)